Scarica l'app Stockscreener
132.00
2.74%
-3.72
Dopo l'orario di chiusura:
131.97
-0.03
-0.02%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$135.72
Aprire:
$134.96
Volume 24 ore:
760.74K
Relative Volume:
1.46
Capitalizzazione di mercato:
$5.59B
Reddito:
$2.81B
Utile/perdita netta:
$-294.68M
Rapporto P/E:
-5.787
EPS:
-22.8098
Flusso di cassa netto:
$232.59M
1 W Prestazione:
-5.69%
1M Prestazione:
-0.75%
6M Prestazione:
+18.03%
1 anno Prestazione:
+1.31%
Intervallo 1D:
$130.99
$135.08
Intervallo di 1 settimana:
$130.99
$140.59
Portata 52W:
$100.18
$145.00
Teleflex Incorporated Stock (TFX) Company Profile
Nome
Teleflex Incorporated
Settore
Industria
Telefono
610-225-6800
Indirizzo
550 E SWEDESFORD RD, WAYNE, PA
Compare TFX vs ISRG, BDX, ALC, RMD, MDLN
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TFX
Teleflex Incorporated
|
132.00 | 5.75B | 2.81B | -294.68M | 232.59M | -22.81 |
ISRG
Intuitive Surgical Inc
|
360.46 | 124.79B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
176.42 | 48.98B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
66.55 | 33.08B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
219.58 | 31.73B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
32.39 | 29.87B | 29.14B | 1.07B | 1.05B | 1.1956 |
Teleflex Incorporated Stock (TFX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-13 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2026-03-27 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2026-01-27 | Aggiornamento | Needham | Hold → Buy |
| 2025-03-04 | Downgrade | BofA Securities | Neutral → Underperform |
| 2025-02-28 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-02-28 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-02-28 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2025-02-27 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-07-01 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-12-04 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-06-21 | Downgrade | Needham | Buy → Hold |
| 2023-05-30 | Iniziato | CL King | Buy |
| 2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-04-26 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2022-10-26 | Iniziato | Mizuho | Neutral |
| 2022-10-14 | Ripresa | Stephens | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-07-29 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-07-06 | Iniziato | Wolfe Research | Outperform |
| 2022-05-09 | Iniziato | BofA Securities | Neutral |
| 2022-04-13 | Iniziato | Truist | Hold |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-10-07 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-09-07 | Ripresa | Raymond James | Outperform |
| 2021-07-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2021-01-06 | Reiterato | Needham | Buy |
| 2020-11-02 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-01-31 | Reiterato | Needham | Buy |
| 2019-08-02 | Reiterato | Needham | Buy |
| 2019-06-11 | Iniziato | Wells Fargo | Outperform |
| 2019-04-24 | Downgrade | Needham | Strong Buy → Buy |
| 2019-02-22 | Reiterato | Needham | Strong Buy |
| 2018-10-16 | Iniziato | Barclays | Equal Weight |
| 2018-09-10 | Aggiornamento | Needham | Buy → Strong Buy |
| 2018-08-03 | Reiterato | Needham | Buy |
| 2018-05-14 | Reiterato | Needham | Buy |
| 2018-05-04 | Reiterato | Needham | Buy |
| 2018-04-04 | Iniziato | Goldman | Neutral |
| 2017-11-10 | Ripresa | Piper Jaffray | Overweight |
| 2017-11-03 | Reiterato | Needham | Buy |
| 2017-09-08 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
| 2017-09-06 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2017-09-06 | Reiterato | Needham | Buy |
| 2017-03-07 | Iniziato | Needham | Buy |
| 2017-01-06 | Aggiornamento | Jefferies | Hold → Buy |
| 2016-07-12 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
Mostra tutto
Teleflex Incorporated Borsa (TFX) Ultime notizie
Director Sean Salmon receives Teleflex (NYSE: TFX) stock and options - Stock Titan
New Teleflex (NYSE: TFX) director Sean Salmon reports no stock stake - Stock Titan
Teleflex (NYSE: TFX) Welcomes Sean M. Salmon to Board, Bringing Expertise from $12.5B Medtronic Cardiovascular Portfolio - Kalkine Media
Teleflex stock heads into the open after a 3.3 percent weekly gain - ad-hoc-news.de
People on the Move: Sean M. Salmon Joins Teleflex Board of Directors - BioBuzz
Surgical Equipment & ConsumablesSpecialty Stocks Q2 Earnings Review: Teleflex (NYSE:TFX) Shines - Yahoo Finance
Teleflex Expands Board, Appoints Sean M. Salmon as New Director - Kalkine Media
Teleflex appoints Sean M. Salmon to board - Medical Buyer
Teleflex elects Sean M. Salmon to board, appoints him to Growth and Operating Committee - TradingView
Teleflex stock holds after a Q2 earnings beat - ad-hoc-news.de
Medtronic veteran joins Teleflex’s board - MassDevice
Teleflex Inc. stock holds steady after strong Q2 earnings beat and updated 2026 guidance - ad-hoc-news.de
Teleflex Appoints Medtronic Veteran Sean Salmon to Board of Directors - citybiz
Teleflex appoints former Medtronic executive to board By Investing.com - Investing.com Nigeria
Teleflex Incorporated Announces Appointment of Sean M. Salmon to Board of Directors and to the Growth and Operating Committee, Effective September 8, 2026 - marketscreener.com
Teleflex Appoints Veteran Medical Technology Executive Sean M. Salmon to Teleflex Board of Directors - Business Wire
Teleflex stock heads into the open after a 0.9 percent gain - ad-hoc-news.de
Teleflex Inc. stock steadies after earnings-driven pullback - ad-hoc-news.de
Teleflex Incorporated (TFX): Stock Analysis Highlights A Promising 10.98% Upside Potential - DirectorsTalk Interviews
Teleflex Inc. stock gains attention as new Dynetic-35 stent debuts at CIRSE 2026 - ad-hoc-news.de
Teleflex Stock Price Forecast. Should You Buy TFX? - StockInvest.us
Teleflex Inc. stock outperforms competitors despite losses on the day - marketwatch.com
Teleflex Inc. stock gains on CIRSE 2026 product spotlight and guidance shift - AD HOC NEWS
Teleflex Sinks ahead of Copenhagen Show - Baystreet.ca
Teleflex to showcase technologies at CIRSE 2026 in Copenhagen - TipRanks
Teleflex Features Innovative Dynetic™-35 Balloon-Expandable Cobalt Chromium Stent System at CIRSE 2026 - Business Wire
Teleflex (TFX): Guidance Cut Meets A Bigger Buyback Push - Yahoo Finance
Teleflex Inc. stock underperforms Tuesday when compared to competitors - marketwatch.com
Teleflex Inc. stock holds steady amid sector recall focus - AD HOC NEWS
Teleflex Inc. stock outperforms competitors on strong trading day - marketwatch.com
Teleflex Incorporated (TFX) Stock Analysis: Exploring Growth Potential With A 9.93% Upside - DirectorsTalk Interviews
How Teleflex Incorporated (TFX) Affects Rotational Strategy Timing - Stock Traders Daily
Teleflex (TFX) Stock Trades At A Discount On Cash Flow But A Premium On Sales - Yahoo Finance
Should You Add Teleflex Stock to Your Portfolio Now? - Yahoo Finance
Teleflex (TFX) Is Up 6.3% After OEM Sale And 2026 EPS UpgradeWhat's Changed - Sahm
Needham raises Teleflex stock price target on Freesolve potential By Investing.com - Investing.com Nigeria
Needham Adjusts Price Target on Teleflex to $170 From $159, Maintains Buy Rating - marketscreener.com
Needham raises Teleflex stock price target on Freesolve potential - Investing.com
Teleflex Incorporated (TFX) Stock Analysis: Exploring A 9.88% Potential Upside For Investors - DirectorsTalk Interviews
Can Teleflex's OEM Sale and Higher EPS Outlook Reshape 2026 Returns? - TradingView
Teleflex: Strong Company Undergoing Messy Transition, Hold (NYSE:TFX) - Seeking Alpha
Teleflex: Portfolio Surgery Creates A Better Medtech Compounder (NYSE:TFX) - Seeking Alpha
Teleflex stock holds recent gains as INGENYX carve-out reshapes its medtech profile - Ad-hoc-news.de
Teleflex stock holds steady after strong Q2 revenue jump - Ad-hoc-news.de
Teleflex stock holds steady after recent gains as investors eye Q2 2026 trends - Ad-hoc-news.de
Pzena Investment Management LLC Purchases Shares of 603,206 Teleflex Incorporated $TFX - MarketBeat
Teleflex Inc. stock underperforms Monday when compared to competitors - MarketWatch
Teleflex (TFX) Completed A $1.5 Billion OEM Divestiture - webull.com
Teleflex Incorporated (TFX) Stock Report: Analyzing a 11.21% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
311,349 Shares in Teleflex Incorporated $TFX Purchased by Diamond Hill Capital Management LLC Investment Advisor - MarketBeat
Teleflex Incorporated (NYSE:TFX) Receives Average Rating of "Hold" from Analysts - MarketBeat
Teleflex Incorporated Azioni (TFX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
14.67%
2.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):